MASK INVESTMENTS (MASKINVEST)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a sharp discount to stated book value: P/B of 0.43, or ₹161.37 per share versus ₹376.17 book value.
• Negligible leverage with Debt/Equity of 0.01, reducing balance-sheet risk.
• High promoter holding of 72.25% aligns insiders with minority shareholders.
• Piotroski F-Score of 7/9 suggests the balance sheet is reasonably healthy on available data.
• Implied total book value of roughly ₹102 Cr versus a market cap of ₹44 Cr provides a theoretical margin of safety if book value is credible.

Concerns

• Latest quarter shows zero sales and zero net profit; there is no current earnings engine, with ROCE of only 0.04% and P/E of 1,000.
• No dividend yield and no sales/profit growth means no return while waiting for value to unlock.
• Stated book value of an investment company may not equal realizable value; underlying assets could be stale, illiquid, or marked incorrectly.
• Small ₹44 Cr market cap and volatile 52-week range suggest limited liquidity and significant price risk.

AI Analysis

What am I to make of MASK Investments? It is an investment company, not an operating business, so I must first admit that I cannot see an economic engine. Sales are zero in the latest quarter, net profit is zero, and ROCE is only 0.04%. That explains the meaningless-looking P/E of 1,000 — there is barely any earnings in the denominator. In Graham's language, this is an asset situation rather than an earnings situation. The one concrete fact that grabs me: the shares trade at ₹161.37 against a stated book value of ₹376.17, a price-to-book of 0.43. That means the market is pricing this at ₹44 Cr of market cap against roughly ₹102 Cr of stated net worth. For a company with debt/equity of only 0.01, that discount is not easily dismissed. The Piotroski F-Score of 7/9 also suggests the balance sheet is not deteriorating, and promoters owning 72.25% gives some comfort that they have skin in the game. But comfort is not conviction. There is no dividend yield, no sales growth, no profit growth, and a PEG of 3.20 means nothing when trailing growth is zero. An investment company is only as good as the real value and liquidity of its underlying holdings. Stated book value can be stale, marked-to-model, or simply unrealizable at that number. With a 52-week range of ₹114.94 to ₹246.09, the price has been volatile, and a small ₹44 Cr market cap means I need a margin of safety bigger than what a balance-sheet ratio alone provides. I would need to see the portfolio, understand each investment, and identify a catalyst for value to emerge. Until then, this is a possible asset play, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer